Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype

Respiratory Medicine

Volumn 109, Issue 11, 2015, Pages 1404-1409

  Konstantellou, Elissavet ^a   Papaioannou, Andriana I ^a   Loukides, Stelios ^a   Patentalakis, George ^a   Papaporfyriou, Anastasia ^a   Hillas, Georgios ^a   Papiris, Spyros ^a   Koulouris, Nikolaos ^a   Bakakos, Petros ^a   Kostikas, Konstantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Airways inflammation; Asthma; Cluster analysis; Persistent airflow obstruction; Phenotype

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; NITRIC OXIDE; OMALIZUMAB; BRONCHODILATING AGENT; GLUCOCORTICOID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLUSTER ANALYSIS; DISEASE DURATION; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PERSISTENT AIRFLOW OBSTRUCTION; PHENOTYPE; PRIORITY JOURNAL; AGED; BREATH ANALYSIS; CLINICAL TRIAL; COMPLICATION; CYTOLOGY; INHALATION TEST; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SPUTUM; VITAL CAPACITY;

ADULT; AGED; AIRWAY OBSTRUCTION; ASTHMA; BREATH TESTS; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CLUSTER ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PHENOTYPE; SPUTUM; VITAL CAPACITY;

EID: 84946566999     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.09.009     Document Type: Article

References (25)

1. Global Initiative for Asthma GINA Workshop Report, Global Strategy for Asthma Management and Prevention 2013 Revised 2013, available on http://www.ginasthma.org
2. S.E. Wenzel Asthma: defining of the persistent adult phenotypes Lancet 368 9537 2006 804 813
3. G.P. Anderson Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease Lancet 372 9643 2008 1107 1119
4. T.B. Kim, A.S. Jang, H.S. Kwon, J.S. Park, Y.S. Chang, S.H. Cho, and et al. Identification of asthma clusters in two independent Korean adult asthma cohorts Eur. Respir. J. 41 6 2013 1308 1314
5. V. Siroux, X. Basagana, A. Boudier, I. Pin, J. Garcia-Aymerich, A. Vesin, and et al. Identifying adult asthma phenotypes using a clustering approach Eur. Respir. J. 38 2 2011 310 317
6. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions Am. Thoracic Soc. Am. J. Respir. Crit. Care Med. 162 6 2000 2341 2351
7. E.H. Bel, A. Sousa, L. Fleming, A. Bush, K.F. Chung, J. Versnel, and et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) Thorax 66 10 2011 910 917
8. M. Kaminska, S. Foley, K. Maghni, C. Storness-Bliss, H. Coxson, H. Ghezzo, and et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction J. Allergy Clin. Immunol. 124 1 2009 45 51 e1-4
9. J.H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B.E. Chipps, and S.E. Wenzel Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study Chest 132 6 2007 1882 1889
10. P. Lange Persistent airway obstruction in asthma Am. J. Respir. Crit. Care Med. 187 1 2013 1 2
11. J.L. Perret, S.C. Dharmage, M.C. Matheson, D.P. Johns, L.C. Gurrin, J.A. Burgess, and et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age Am. J. Respir. Crit. Care Med. 187 1 2013 42 48
12. E. Tseliou, P. Bakakos, K. Kostikas, G. Hillas, K. Mantzouranis, P. Emmanouil, and et al. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma Allergy 67 3 2012 396 402
13. A. Efthimiadis, A. Spanevello, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, and et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur. Respir. J. Suppl. 37 2002 19s 23s
14. J.C. Kips, J.V. Fahy, F.E. Hargreave, P.W. Ind, and J.C. in't Veen Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma Eur. Respir. J. Suppl. 26 1998 9S 12S
15. D.C. Grootendorst, J.W. van den Bos, J.J. Romeijn, M. Veselic-Charvat, E.J. Duiverman, E.J. Vrijlandt, and et al. Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity Eur. Respir. J. 13 3 1999 647 653
16. Standardization of Spirometry, 1994 update Am. Thoracic Soc. Am. J. Respir. Crit. Care Med. 152 3 1995 1107 1136
17. R.O. Crapo, R. Casaburi, A.L. Coates, P.L. Enright, J.L. Hankinson, C.G. Irvin, and et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999 Am. J. Respir. Crit. Care Med. 161 1 2000 309 329
18. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005 Am. J. Respir. Crit. Care Med. 171 8 2005 912 930
19. P. Haldar, I.D. Pavord, D.E. Shaw, M.A. Berry, M. Thomas, C.E. Brightling, and et al. Cluster analysis and clinical asthma phenotypes Am. J. Respir. Crit. Care Med. 178 3 2008 218 224
20. A. Ten Brinke, A.H. Zwinderman, P.J. Sterk, K.F. Rabe, and E.H. Bel Factors associated with persistent airflow limitation in severe asthma Am. J. Respir. Crit. Care Med. 164 5 2001 744 748
21. W.C. Moore, D.A. Meyers, S.E. Wenzel, W.G. Teague, H. Li, X. Li, and et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program Am. J. Respir. Crit. Care Med. 181 4 2010 315 323
22. C. Newby, L.G. Heaney, A. Menzies-Gow, R.M. Niven, A. Mansur, C. Bucknall, and et al. Statistical cluster analysis of the British thoracic society severe refractory asthma registry: clinical outcomes and phenotype stability PLoS One 9 7 2014 e102987
23. S.W. Park, J.S. Park, S.H. Jeong, Y.N. Lee, Y. Hwangbo, J.H. Lee, and et al. Air trapping is a major determinant of persistent airway obstruction in asthmatics Respir. Med. 106 6 2012 786 793
24. M. Ciebiada, M. Domagala, M. Gorska-Ciebiada, and P. Gorski Risk factors associated with irreversible airway obstruction in nonsmoking adult patients with severe asthma Allergy Asthma Proc. 35 5 2014 72 79
25. A.F. Gelb, A. Yamamoto, E.K. Verbeken, and J.A. Nadel Unraveling the pathophysiology of the asthma-COPD overlap syndrome: unsuspected mild centrilobular emphysema is responsible for loss of lung elastic recoil in never smokers with asthma with persistent expiratory airflow limitation Chest 148 2 2015 313 320